ANDA 212564, held by Yabao Pharm. Celecoxib.
As of Nov 15, 2026, ANDA 212564 (Celecoxib), held by Yabao Pharm, was first approved by FDA on Apr 10, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 10, 2023 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters